Notably, PCSK9 expression is markedly elevated in T2DM and has been shown to correlate positively with major adverse cardiovascular events (MACEs), suggesting its potential pathogenic involvement in DCM warrants further investigation. The gene discussed is PCSK9; the disease is type 2 diabetes mellitus.